See the Complete Picture.
Published loading...Updated

Pfizer's Paxlovid not included in China's national insurance

Summary by CTV News
China's health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.

53 Articles

All
Left
24
Center
16
Right
4
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 55% of the sources lean Left
55% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Reuters broke the news in United Kingdom on Sunday, January 8, 2023.
Sources are mostly out of (0)